CD44 and cancer: Numerous researchers have revealed that a particular subdivision of CTCs can express stem cell markers (e.g., CD133 [12] or CD44 [20]), can have cells with cancer stem cell characteristics [21, 22], and can thus be considered circulating cancer stem-like cells (cCSCs) [23].